Specified Drug-Use Survey of Alogliptin and Metformin Hydrochloride Combination Tablets Survey on long-term use in type 2 diabetes mellitus patients with renal or hepatic impairment or advanced age

Takeda Pharmaceutical Company Limited0 个研究点目标入组 1,026 人开始时间: 2018年6月1日最近更新: 2023年10月17日

适应症

试验速览

阶段: Unknown
状态: 已完成
发起方: Takeda Pharmaceutical Company Limited
入组人数: 1,026

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

The results above showed no new concerns regarding the long-term safety and efficacy of this drug in patients with type 2 diabetes mellitus with renal or hepatic impairment or advanced ages (>= 65 years) and suggested a relationship between the improvement in the medication adherence after switching medication to this product and efficacy in participants taking alogliptin benzoate and metformin hydrochloride in combination.

研究设计

研究类型: Observational

入排标准

年龄范围: ot applicable 至 ot applicable（—）
性别: All

入选标准

•Participants should meet one or more of the following:
•1. Have renal impairment (mild)
•2. Have hepatic impairment (mild or moderate)
•3. Elderly (aged 65 years or more)

排除标准

•Participants with any contraindication for study drug.

研究者

发起方

Takeda Pharmaceutical Company Limited

相似试验

已完成

不适用

Specified Drug-Use Survey of Alogliptin and Metformin Hydrochloride Combination Tablets "Survey on Long-term Use in Type 2 Diabetes Mellitus Patients With Renal or Hepatic Impairment or Advanced Age"Type 2 Diabetes Mellitus

NCT03555565Takeda1,026

已完成

Unknown

Specified Drug-Use Survey of Trelagliptin Tablets Survey on long-term use in patients with type 2 diabetes mellitusType 2 Diabetes Mellitus

JPRN-jRCT1080223923Takeda Pharmaceutical Company Limited3,198

已完成

不适用

Alogliptin/Pioglitazone (Liovel) Combination Tablets Survey on Long-term Use in Patients With Type 2 Diabetes MellitusType 2 Diabetes Mellitus

NCT01990300Takeda3,281

已完成

不适用

Alogliptin Tablets Special Drug Use Surveillance "Type 2 Diabetes Mellitus: Monotherapy/Combination Therapy With α-GI"Type 2 Diabetes Mellitus Who Have Been Examined at a Medical Institution

NCT01945216Takeda3,317

已完成

不适用

Alogliptin Tablets Special Drug Use Surveillance: Mild Type 2 Diabetes MellitusType 2 Diabetes Mellitus

NCT01964963Takeda19,192